Search Results - Paul Slobbe
- Showing 1 - 1 results of 1
-
1
A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [11C]erlotinib and [18F]afatinib in lung cancer-bearing mice by Paul Slobbe, Albert D. Windhorst, Marijke Stigter‐van Walsum, Egbert F. Smit, Heiko G. Niessen, Flavio Solca, G. Stehle, Guus A.M.S. van Dongen, Alex J. Poot
Published 2015Artigo